Company Filing History:
1 out of 3,540 
1 out of 52 
Years Active: 2013
Title: Aniko Goblyos: Innovator in Allosteric Modulation of Adenosine Receptors
Introduction
Aniko Goblyos is a notable inventor based in Zoetermeer, Netherlands. She has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of adenosine receptors. Her innovative work has led to the development of a patent that holds promise for therapeutic applications.
Latest Patents
Aniko Goblyos holds a patent related to the allosteric modulation of adenosine receptors (AAR). The patent describes the use of an adenosine receptor modulator (ARM) for preparing pharmaceutical compositions aimed at modulating AAR in subjects. The ARM includes novel 1H-Imidazo-[4,5-c]quinolin-4-amine derivatives, which are crucial for effective modulation of AAR activity. This patent represents a significant advancement in the field of pharmacology, with potential implications for various therapeutic methods.
Career Highlights
Throughout her career, Aniko Goblyos has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Universiteit Leiden. Her experience in these institutions has enriched her expertise and contributed to her innovative research.
Collaborations
Aniko has collaborated with esteemed colleagues such as Johannes Brussee and Adriaan Pieter Ijzerman. These collaborations have fostered a productive environment for research and development in her field.
Conclusion
Aniko Goblyos is a pioneering inventor whose work in allosteric modulation of adenosine receptors has the potential to impact pharmaceutical sciences significantly. Her contributions and collaborations highlight her commitment to advancing medical research and innovation.